• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Clinical Laboratory Services - Global Strategic Business Report Product Image

Clinical Laboratory Services - Global Strategic Business Report

  • Published: January 2014
  • Region: Global
  • 403 Pages
  • Global Industry Analysts, Inc

This report analyzes the worldwide markets for Clinical Laboratory Services in US$ Million by the following Product Segments: Hospital-Based Laboratories, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2012 through 2020. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based on public domain information including company URLs. The report profiles164 companies including many key and niche players such as:

- ADICON Clinical Laboratories, Inc.
- ARUP Laboratories
- Asuragen, Inc.
- Atherotech Diagnostics Lab
- Bio-Reference Laboratories, Inc.
- Clarient, Inc.

CLINICAL LABORATORY SERVICES

MCP-6952 A GLOBAL STRATEGIC BUSINESS REPORT
CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Hospital-Based Medical Laboratories
Others
Physician’s Office-Based Medical Labs
Independent Laboratories

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW
Prelude
Despite Challenges, Emerging Markets Provide Growth Opportunities
Developed Nations: Cost Pressures Necessitate New Strategies
Economic Uncertainty Affects Spending on Healthcare Services
Major Growth Drivers: A Review
Rising Healthcare Needs of Aging Global Population
Table 1: Over-65 Years Population as a % of Total Population (2010 & 2020P) (includes corresponding Graph/Chart)
Table 2: Elderly Population (65+ Years) as a % of Total Population (2000 & 2025) (includes corresponding Graph/Chart)
Table 3: Global Population Statistics for the 65+ Age Group (2012) (includes corresponding Graph/Chart)
Table 4: Life Expectancy Rates at Birth by Geographic Region (1990 & 2011) (includes corresponding Graph/Chart)
Increase in Healthcare Spending in Emerging Markets
Table 5: Healthcare Spending as % of GDP in Select Countries (2011) (includes corresponding Graph/Chart)
Increasing Awareness Levels
Need to Cut Healthcare Costs
Rising Incidence of Diseases
World Cancer Statistics: Incidence and Mortality Data
Table 6: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
Table 7: World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer-Related Deaths (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
Table 8: New Cancer Cases in the World by Affected Site (2012) (In Thousands) (includes corresponding Graph/Chart)
Table 9: Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal and Liver Cancers (includes corresponding Graph/Chart)
Table 10: Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung & Bronchus and Liver Cancers (includes corresponding Graph/Chart)
Table 11: Global Cancer Mortality in Men for Select Cancers (2012): Number of Deaths in Thousands for Lung & Bronchus, Liver, Colorectal and Prostate Cancers (includes corresponding Graph/Chart)
Table 12: Global Cancer Mortality in Women for Select Cancers (2012): Number of Deaths in Thousands for Breast, Lung & Bronchus, Colorectal and Liver (includes corresponding Graph/Chart)
Cancer Prone Sites based on Age
Global HIV Statistics
Table 13: Global Summary of the AIDS Epidemic in 2011 (includes corresponding Graph/Chart)
Some Significant HIV Statistics by Region (2011)
Increasing Role of Clinical Labs in Testing of Infectious Diseases
Table 14: Reported Cases of Major Infectious by Geographic Region (2011)
Esoteric Testing Market: Faster Growth than Routine Testing Segment
Increasing Role of Advanced Tests in Clinical Treatment Decision Making
Opportunities in Personalized Medicine and Clinical Trial Services
Clinical Labs Opt for Reagent Rental Contracts to Sustain Operations
Cancer Testing Market: Opportunity for Clinical Labs
Shortened Hospitalization Enhances Significance of Medical Labs
Lab Automation Speeds Up
Heightened Use of IT Systems in Clinical Laboratories
Laboratory Outsourcing Trend Gains Strength
Autoimmune Disease Testing: Labs Seek Cost-Effective & High Productivity Options
Assessing the Impact of Point-of-Care Testing on Clinical Labs
IVD Market Growth: An Indication of Growth in Clinical Labs Market
Laboratory Budget Allocations Affected by Prevailing Economic Environment
POLs: Reducing Turnaround Times for Testing
Challenges Facing Lab Testing Market

2. COMPETITIVE LANDSCAPE
Introduction
Quest Diagnostics & LabCorp: The Leading Independent Labs
Consolidation Activity Continues to Strengthen
Major Clinical Laboratory Transactions (2011-2013)

3. CLINICAL LABORATORY SERVICES - AN INTRODUCTION
Clinical Laboratory Services
What is a Medical Laboratory?
Laboratory Medicine
Anatomic Pathology
Clinical Pathology
Types of Tests Conducted in Medical Labs
Routine Tests
Esoteric Tests
Anatomic Pathology Services
Types of Clinical Laboratories
Hospital-Based Laboratories
Physician’s Office-Based Medical Labs
Reference Laboratories
Potential Customers for Medical Laboratories
Work Process in Clinical Labs
Specimen Processing & Result Analysis in Clinical Labs
Laboratory Information Systems
Conducting Lab Tests
Key Personnel in Medical Labs
Role of Medical Technologists
Role of Medical Technicians
Analysis, Validation and Interpretation of Results
Testing Equipment
Bio-Safety Hazards and Equipment Design
Essential Bio-safety Equipment in Clinical Laboratories
Personal Protection Equipment in Medical Labs
Economic Model Followed By Testing Laboratories
Revenues
Expenses
Dichotomy between Customers and Payers in Medical Lab Industry
Impact of Environmental Factors on Lab Tests
Regulatory Overview
Legislative & Regulatory Environment Worldwide
GCLP
ISO 15189:2003
ISO 15189 Accreditation
ILAC

4. PRODUCT INNOVATIONS/INTRODUCTIONS
Genomic Health Launches Oncotype DX Prostate Cancer Test
Clarient Rolls Out Next-Generation Sequencing Assay
SilverStaff Clinical Laboratories to Provide BGM Galectin-3® Test of BG Medicine
Quest Diagnostics Unveils Dementia Clinical Diagnostic Panel
Psychemedics Unveils Hair Alcohol Test
Prometheus Laboratories Introduces PROMETHEUS® Anser™ ADA
NeoGenomics Launches Clinical Molecular Tests for MDS
LipoScience Introduces Vantera Clinical Analyzer for Cardiovascular Disease Management
Atherotech Diagnostics Lab Introduces AspirinWorks® Test
GeneDx to Introduce Comprehensive Genetic Tests Suite for Ovarian and Breast Cancers
Enzo Clinical Labs Collaborates with Oncimmune to Launch Novel Diagnostic Test
Myriad RBM Introduces Oncology® v. 2.0 Test
NeoGenomics Introduces NeoSITE™ Barrett’s Esophagus FISH Test
diaDexus Introduces CE marked PLAC Test for Lp-PLA(2) Activity

5. RECENT INDUSTRY ACTIVITY
Quest Diagnostics Acquires Dignity Health’s Clinical Operations
Quest Diagnostics Takes Over Laboratory Operations of Concentra
LifeLabs Acquires BC Biomedical
JLL Takes Over BioClinica and CoreLab
Quest Diagnostics Takes Over ConVerge Diagnostic Services
Spectra Laboratories Acquires Shiel Medical Laboratory
Gamma-Dynacare Medical Acquires Controlling Stake in Impact Genetics
Proove Biosciences Takes Over Colwell Clinical Labs
BioReference to Acquire Laboratory Business of Edge BioSystems
Cleveland Clinic Laboratories Signs Agreement with ACL for Specialized Testing Services
Cancer Genetics and Mayo Clinic Establish JV, Oncospire Genomics
HDL to Form Joint Venture with GeneNews for ColonSentry Test
Gamma-Dynacare Collaborates with OSR Medical
Mayo Medical and Mayo Clinic in Collaboration Agreement with bioTheranostics
MACL & Oncimmune® Offer EarlyCDT®-Lung Blood Test
Luminex and NMTC Collaborate for Lab-Developed Panel
ARUP Partners with Predictive Biosciences
PrimeraDx and Quest Diagnostics Ink Co-Development Agreement
DaVita Labs Inks Research Collaboration Agreement with Myriad RBM
Rochester General Health System Inks Partnership Agreement with Mayo Medical Laboratories
Corgenix Medical Inks Agreement with Atherotech Diagnostics Lab
MDxHealth Inks Marketing Partnership with Bostwick Laboratories
ARUP Laboratories Inks Agreement with Oncimmune®
Instituto Hermes Pardini Takes Over Diagnostika - Unidade de Patologia e Citologia
LifeLabs Medical Laboratory Acquires CML HealthCare
Mayo Medical Conducts NMR Lipoprotein Particle Testing with LipoScience Vantera® Clinical Analyzer
Bio-Reference Signs Agreement with Natera to Commercialize Panorama™ NIPT
Myriad Genetics Signs Companion Diagnostic Deal with TESARO
OpGen Establishes CLIA-Certified Clinical Services Laboratory and Introduces Microbial Genetic Tests for HAIs
Echevarne to Distribute Natera’s Panorama™ Prenatal Test Panorama in Spain
AccelPath Acquires DigiPath
OPKO Health Takes Over Prost-Data
Ampersand Takes Over Willow Laboratories
LabCorp Takes Over MEDTOX
WCP Takes Over Sterling Reference Laboratories
Gamma-Dynacare to Take Over LifeLabs Quebec
Quest Diagnostics Takes Over S.E.D. Medical Laboratories
TrovaGene Acquires MultiGEN Diagnostics Clinical Laboratory Business
Bode Technology Group Takes Over Chromosomal Laboratories
Becton, Dickinson and Company Takes Over KIESTRA Lab Automation
CD Diagnostics Acquires Stake in CML
Quest Diagnostics to Acquire UMass' Clinical Laboratory Outreach Business
AmperSand Capital to Acquire Calloway
Genova Diagnostics and Metametrix Merge Operations
Al Borg to Merge Operations with Al Mokhtabar
InCyte Pathology Signs Preliminary Merger Deal with Eastside Pathology
Gamma-Dynacare Acquires Alcohol and Drug Testing Business of Maxxam Analytics
ADICON Inks Strategic Collaboration Framework Contract with Siemens
Myriad RBM Signs Collaboration Agreement with Sanofi and PHRI for Protein Bio-marker Research
DLMP and MML Collaborate with Kindstar for Esoteric Tests
Qiagen Signs Co-Marketing Pact with KingMed Diagnostics
WuXi PharmaTech Enters into JV Agreement with PRA
AKUH Establishes High-Tech Stat Laboratory in Rawalpindi
Warburg Pincus Collaborates with Lab Industry Veterans to Launch RDL
Covance and BML Expand CB Trial Lab
Bio-Reference Laboratories to Establish Laboratorio Buena Salud
The University of Western Australia Establishes Translational Cancer Pathology Laboratory
Khandelwal Laboratories Establishes KLab in Nepal
6. FOCUS ON SELECT PLAYERS
ADICON Clinical Laboratories, Inc. (China)
ARUP Laboratories (US)
Asuragen, Inc. (US)
Atherotech Diagnostics Lab (US)
Bio-Reference Laboratories, Inc. (US)
Bioscientia Institut für Medizinische Diagnostik GmbH (Germany)
Clarient, Inc. (US)
DaVita, Inc. (US)
Enzo Clinical Labs (US)
Gaoxin - Da an Health Investment Ltd. (China)
Gamma-Dynacare Medical Laboratories (Canada)
Genoptix Medical Laboratory (US)
Genova Diagnostics, Inc. (US)
Kingmed Diagnostics (China)
Healthscope Ltd. (Australia)
Laboratory Corporation of America Holdings (US)
Labco S.A. (France)
Mayo Medical Laboratories (US)
Myriad Genetic, Inc. (US)
Pathology, Inc. (US)
Prometheus Laboratories, Inc. (US)
Quest Diagnostics, Inc. (US)
Sonic Healthcare Limited (Australia)
American Esoteric Laboratories (US)
Spectra Laboratories, Inc. (US)
Thyrocare Technologies Limited (India)
The National Health Laboratory Service (South Africa)
Unilabs SA (Switzerland)

7. GLOBAL MARKET PERSPECTIVE
Table 15: World Recent Past, Current and Future Analysis for Clinical Laboratory Services by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
Table 16: World Historic Review for Clinical Laboratory Services by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
Table 17: World 15-Year Perspective for Clinical Laboratory Services by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 18: World Recent Past, Current and Future Analysis for Hospital-based Medical Laboratories by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
Table 19: World Historic Review for Hospital-based Medical Laboratories by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
Table 20: World 15-Year Perspective for Hospital-based Medical Laboratories by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 21: World Recent Past, Current and Future Analysis for Other Laboratories by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
Table 22: World Historic Review for Other Laboratories by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
Table 23: World 15-Year Perspective for Other Laboratories by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A.Market Analysis
Clinical Laboratories: A Small Yet Vital Constituent of Healthcare Industry
Table 24: US Healthcare Spending (2012): Percentage Share Breakdown of Spending by Segment - Hospitals, Professional Services, Prescriptions, Medical Products, Laboratory Testing, and Others (includes corresponding Graph/Chart)
Changing Healthcare Industry Dynamics Affect Clinical Lab Testing Market
Table 25: Healthcare Spending as a % of GDP (includes corresponding Graph/Chart)
Positive Outlook for Clinical Laboratory Services Market
Current and Future Analysis
A Glance at Major Growth Drivers
Unmet Diagnostic Needs of Aging Population
Table 26: North American Elderly Population by Age Group (1975-2050) (includes corresponding Graph/Chart)
Table 27: US Population Breakdown by Age Group (2012) (includes corresponding Graph/Chart)
Increasing Burden of Chronic Diseases Drives Focus onto Early Detection & Prevention
Cancer Statistics in the US
Table 28: New Cancer Cases by Gender and Affected Site in the US (2013)
Prevalence of Diabetes Mellitus in North America
Table 29: Prevalence of Diabetes Mellitus in North America (2012) (includes corresponding Graph/Chart)
Opportunities in Personalized Medicine and Clinical Trial Services
Increasing Reimbursement Pressures - Opportunities for Testing Services
Growing Focus on Early Diagnosis
Impact of Scientific Advances & Role of Healthcare IT Solutions
Need to Reduce Healthcare Costs
Legislative, Regulatory and Policy Environment
Opportunities for Individual Testing
Population Screening Initiatives
Challenges Facing Clinical Labs Market
Product-Related Trends
Table 30: Clinical Laboratory Testing Market in the US (2010): Percentage Share Breakdown of Revenues by Segment (includes corresponding Graph/Chart)
Routine Tests: The Largest Product Category
Anatomic Pathology & Cytology Testing: Personalized Medicine Presents Positive Future
Table 31: US Market for Outpatient Anatomic Pathology Testing (2010): Percentage Share Breakdown of Revenues by Test Type - Pap Smears, Skin Biopsies, Gynecology Biopsies, Prostate, Gastrointestinal, and Others (includes corresponding Graph/Chart)
Esoteric Testing Market: Faster Growth than Routine Testing Segment
Molecular Diagnostics: Promising Growth Opportunities
Drugs of Abuse Testing: Prospects Linked to Employment Levels
Future Holds Promise for Specialty Testing Market
Impact of Healthcare Spending Cuts on Routine & Specialty Lab Tests
Increasing Role of Advanced Tests in Clinical Treatment Decision Making
Tissue-based Diagnostics Market to Expand
Toxicology Laboratories Market: An Insight
Genetic and Genomic Clinical Lab Testing Market: Promising Prospects
Shift towards Managed Care - A Challenge for Independent Clinical Labs?
Evolving ACO Business Model: A Challenge for Independent Labs
Integration of Clinical Care: Impact on Clinical Labs & Anatomic Pathology Groups
Hospital Laboratory Outreach Programs: On the Rise
Physician Practices: The New Acquisition Targets
Table 32: % of Independent Physicians in the US (2005-2013) (includes corresponding Graph/Chart)
Cost Cutting Measures to Hit Lab Outreach Testing Business?
Hospitals Foray into Health Insurance Market: Opportunities for Hospital Labs
FDA to Regulate Laboratory Developed Tests (LDTs)
Shortened Hospital Stay Enhances Significance of Medical Labs
Lab Automation: A Key Trend in the Clinical Laboratory Testing Market
Health Plans Interpose Between Clinical Labs and Physicians
POCT Segment Withstands Cost Pressures
Dealing with Regulatory Changes: A Tough Ask for Clinical Labs
CMS Proposes to Slash Payment for Lab Tests
Providers of Clinical Laboratory Service in the US: A Review
Hospital-Based Labs
Table 33: Hospital Lab Test Market in the US (2012): Percentage Share Breakdown of Revenues by Payer (includes corresponding Graph/Chart)
Table 34: Registered Hospitals in the US (2012): Percentage Share Breakdown of Number of Hospitals by Type of Hospital (includes corresponding Graph/Chart)
Independent Labs
Table 35: Independent Labs Market in the US (2012): Percentage Share Breakdown of Revenues for Quest Diagnostics, LabCorp, Small Independent Labs, Niche Labs, and Tier 2 Labs (includes corresponding Graph/Chart)
Physician Office-Based Labs and Others
Competitive Landscape
Consolidation Activity Gathers Pace in Clinical Laboratory Testing Market
Table 36: Number of Closed M&A Transactions in the US Clinical Labs Market (2005-2012) (includes corresponding Graph/Chart)
Table 37: Closed M&A Transactions in the US Clinical Labs Market (2009-2012): Breakdown by Clinical Labs and Anatomic Pathology & Specialty Labs (includes corresponding Graph/Chart)
Major Clinical Laboratory Transactions (2011-2013)
Regulatory Landscape
A2LA
ASCLS
CAP
Clinical Laboratory Improvement Amendments (CLIA)
Table 38: CLIA-Certified Laboratories in the US (2013): Percentage Share Breakdown of Number of Laboratories by Certificate Type (includes corresponding Graph/Chart)
Table 39: CLIA-Certified Laboratories in the US (2013): Percentage Share Breakdown of Number of Labs by Lab Type (includes corresponding Graph/Chart)
Health Insurance Portability and Accountability Act of 1996
Substance Abuse and Mental Health Services Administration (SAMHSA) Regulation
Reimbursement Scenario for Clinical Laboratory Tests
Impact on Funding Changes on Clinical Labs Testing Market
Medicare Coverage for Screening Tests
Medicare Clinical Laboratory Fee Schedule (CLFS)
Medicare Physician Fee Schedule (MPFS)
Medicaid
Payment and Coding for Clinical Laboratory Testing Services
Table 40: Medicare Spending in the US (2012): Percentage Share Breakdown of Spending by Category - Inpatient Hospital, Managed Care, Prescription Drugs, Physician Fee Schedule, SNF, Home Health, Hospice, Clinical Laboratory, and Others (includes corresponding Graph/Chart)
Product Innovations/Introductions
Strategic Corporate Developments
Key Players
B.Market Analytics
Table 41: US Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
Table 42: US Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
Table 43: US 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, Independent Laboratories, and Physician Office Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

2. CANADA
A.Market Analysis
Outlook
Rising Incidence of Chronic Diseases Spurs Need for Testing
Table 44: New Cancer Cases in Canada by Gender and Affected Site (2012) (includes corresponding Graph/Chart)
Table 45: New Cancer Cases in Canada by Province (2012) (includes corresponding Graph/Chart)
Table 46: New Cancer Cases in Canada by Age Group and Gender (2012) (includes corresponding Graph/Chart)
Table 47: Prevalence of Diabetes Mellitus in Canada (2012) (includes corresponding Graph/Chart)
Funding Crunch Bolsters Consolidation Activity among Independent Labs
Regulatory Scenario in Canada
Accreditation Canada
Standards Council of Canada
Strategic Corporate Developments
Gamma-Dynacare Medical Laboratories - A Key Player
B.Market Analytics
Table 48: Canadian Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location
Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
Table 49: Canadian Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
Table 50: Canadian 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

3. JAPAN
A.Market Analysis
Outlook
Demographics Drive Market Growth
Table 51: Percentage Breakdown of Japanese Population by Age Group (2012) (includes corresponding Graph/Chart)
Table 52: Over 65 Years Population in Japan (1950-2010) (includes corresponding Graph/Chart)
Table 53: Prevalence of Diabetes Mellitus in Japan (2012 & 2030) (includes corresponding Graph/Chart)
Strategic Corporate Development
B.Market Analytics
Table 54: Japanese Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location
Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
Table 55: Japanese Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
Table 56: Japanese 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4. EUROPE
A.Market Analysis
Outlook
Overview
Table 57: Diagnostics Market in Europe (2012): Percentage Share Breakdown of Revenues by Medical Imaging, Laboratory Testing, and Anatomic Pathology (includes corresponding Graph/Chart)
Debt Crisis in Europe Affects Healthcare Industry
European Healthcare System: In a State of Transition?
Aging Population to Drive Demand for Medical Laboratory Services
Table 58: Population Breakup by Age Group for Select European Countries: 2012 (As a % of Total Population) (includes corresponding Graph/Chart)
Accreditation and Regulatory Scenario in the EU
B.Market Analytics
Table 59: European Recent Past, Current and Future Analysis for Clinical Laboratory Services by Geographic Region
France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
Table 60: European Historic Review for Clinical Laboratory Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
Table 61: European 15-Year Perspective for Clinical Laboratory Services by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 62: European Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location
Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
Table 63: European Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
Table 64: European 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
4a. FRANCE
A.Market Analysis
Outlook
Overview
Table 65: 65+ Population as % of Total Population (includes corresponding Graph/Chart)
Table 66: Clinical Testing Laboratories in France (2012): Percentage Share Breakdown of Number of Labs by Type (includes corresponding Graph/Chart)
Labco S.A. - A Key Player
B.Market Analytics
Table 67: French Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location
Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
Table 68: French Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
Table 69: French 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
4b. GERMANY
A.Market Analysis
Outlook
Privatization: A Visible Trend in the Labs Market
Regulatory Scenario in Germany
DAkkS GmbH - Germany’s National Accreditation Body
Bioscientia Institut für Medizinische Diagnostik GmbH - A Key Player
B.Market Analytics
Table 70: German Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location
Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
Table 71: German Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
Table 72: German 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
4c. ITALY
A.Market Analysis
Outlook
ACCREDIA - The Italian Accreditation Body
B.Market Analytics
Table 73: Italian Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location
Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
Table 74: Italian Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
Table 75: Italian 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
A.Market Analysis
Outlook
UKAS - The Sole National Accreditation Body in the UK
B.Market Analytics
Table 76: UK Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
Table 77: UK Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
Table 78: UK 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
4e. SPAIN
A.Market Analysis
Outlook
Strategic Corporate Development
B.Market Analytics
Table 79: Spanish Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location
Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
Table 80: Spanish Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
Table 81: Spanish 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
4f. RUSSIA
Market Analysis
Table 82: Russian Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location
Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
Table 83: Russian Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
Table 84: Russian 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
4g. REST OF EUROPE
A.Market Analysis
Outlook
Poland
Switzerland
Ukraine
Strategic Corporate Developments
Unilabs SA (Switzerland) - A Key Player
B.Market Analytics
Table 85: Rest of Europe Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location
Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
Table 86: Rest of Europe Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
Table 87: Rest of Europe 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC
A.Market Analysis
Overview
Healthcare Spending in Asia-Pacific: On the Rise
China and India: Two Fast-Growing Markets
APLAC - A Regional Accreditation Body in Asia-Pacific
B.Market Analytics
Table 88: Asia-Pacific Recent Past, Current and Future Analysis for Clinical Laboratory Services by Geographic Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
Table 89: Asia-Pacific Historic Review for Clinical Laboratory Services by Geographic Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
Table 90: Asia-Pacific 15-Year Perspective for Clinical Laboratory Services by Geographic Region - Percentage Breakdown of Revenues for China and Rest of Asia-Pacific Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
Table 91: Asia-Pacific Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location
Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
Table 92: Asia-Pacific Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
Table 93: Asia-Pacific 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
5a. CHINA
A.Market Analysis
Outlook
Medical Labs Market: An Overview
Healthcare Reforms: Opportunities for Clinical Labs Market
Independent Clinical Labs - A Nascent Market
Table 94: Leading Independent Medical Labs in China (2013): Percentage Share Breakdown of Revenues for KingMed Diagnostics, DiAn Diagnostics, Adicon Clinical Laboratories Inc., DaAn Health, and Others (includes corresponding Graph/Chart)
CNAL - The National Accreditation Body in China
HKAS - An Accreditation Body in Hong Kong
Strategic Corporate Developments
Key Players
B.Market Analytics
Table 95: Chinese Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location
Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
Table 96: Chinese Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
Table 97: Chinese 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
5b. REST OF ASIA-PACIFIC
A.Market Analysis
Outlook
Review of Select Regional Markets
Australia
Strong Growth in Lab Testing Leads to Increased Private Health Insurance Premiums
NATA - An Australian Regulatory Agency
India
Clinical Laboratory Market: Overview
Growth Drivers
Challenges
Table 98: Indian Medical Laboratories Market (2010): Percentage Share Breakdown of Revenues by Type of Lab
High-End Labs, Regional Labs, and Manual Labs (includes corresponding Graph/Chart)
Table 99: Indian Clinical Laboratory Market (2013E): Percentage Share Breakdown of Revenues by Segment
Biochemistry, Immunology, Hematology, Microbiology, Histopathology, Molecular, and Genetics (includes corresponding Graph/Chart)
Biochemistry Analysis: An Important Clinical Lab Segment
Competitive Landscape
Business Model of Medical Labs
Table 100: Indian Medical Laboratories Market (2013)): Number of Labs and Collection Centers Operated by Metropolis, SRL Diagnostics, and Dr. Lal Path Labs
Regulatory Scenario in India
Indonesia
Korea
Rapidly Aging Population Spurs Demand for Clinical Lab Testing
Table 101: South Korean Medical Laboratories Market (2010): Percentage Share Breakdown of Medical Laboratories by Healthcare Segment - Immunochemistry, Infectious Disease, Clinical Chemistry, Microbiology, Hematology, Molecular Biology, and Others (includes corresponding Graph/Chart)
KOLAS - The National Accreditation Agency of Korea
Philippines
Regulatory Scenario in Philippines
Singapore
SAC - The National Agency for Accreditation in Singapore
Thailand
BLQS - A Designated Accreditation Authority in Thailand
Strategic Corporate Developments
Key Players
B.Market Analytics
Table 102: Rest of Asia-Pacific Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location
Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
Table 103: Rest of Asia-Pacific Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
Table 104: Rest of Asia-Pacific 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

6. LATIN AMERICA
A.Market Analysis
Outlook
Brazil
Overview
Table 105: Anatomic Pathology Test Labs in Brazil (2012): Percentage Share Breakdown of Number of Labs by Region (includes corresponding Graph/Chart)
INMETRO - The National Accreditation Body of Brazil
Chile
Strategic Corporate Development
B.Market Analytics
Table 106: Latin American Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location
Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
Table 107: Latin American Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
Table 108: Latin American 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

7. REST OF WORLD
A.Market Analysis
Outlook
Medical Laboratories in Sub-Saharan Africa
East Africa
West Africa
Nigeria
South Africa
Regulatory Environment in South Africa
Strategic Corporate Development
The National Health Laboratory Service (South Africa) - A Key Player
B.Market Analytics
Table 109: Rest of World Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location
Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2012 through 2020 (includes corresponding Graph/Chart)
Table 110: Rest of World Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, and Other Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2011 (includes corresponding Graph/Chart)
Table 111: Rest of World 15-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, and Other Laboratories Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 164 (including Divisions/Subsidiaries - 167)
The United States (115)
Canada (11)
Japan (1)
Europe (15) - France (1) - Germany (2) - The United Kingdom (5) - Spain (1) - Rest of Europe (6)
Asia-Pacific (Excluding Japan) (15)
Latin America (1)
Africa (5)
Middle East (4)

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos